Le Lézard
Classified in: Health
Subjects: LEG, POL, STP, AVO

Physician to Testify Before New York Legislature on Assisted Suicide


NEW YORK, May 3, 2018 /PRNewswire/ -- T. Brian Callister, M.D. of Reno, Nevada, will testify this morning before a New York State Assembly health committee in New York City regarding his opposition to physician-assisted suicide and euthanasia. Callister is an internationally recognized expert on care transitions and end-of-life care. He has practiced medicine for 30 years and is currently an associate professor of medicine at the University of Nevada, Reno School of Medicine.

"I look forward to sharing my experiences which have resulted in my passionate opposition to physician-assisted suicide with the New York Assembly members," Callister said. "There is a growing ground-swell of insurance companies who believe that physician-assisted suicide is better for patients without consideration of the quality of life, because for them, it's the least-expensive option."

Callister said he has seen this first hand when two different patients were denied potentially life-saving procedures, with the insurance companies suggesting that physician-assisted suicide might be a better solution.

The New York State Assembly is currently holding hearings regarding a legislative bill (A.2383-A --Paulin) to pass a state law in favor of physician-assisted suicide. The Assembly began hearings on the bill in Albany during April and continues through today in Manhattan.

About Dr. Callister

T. Brian Callister, M.D., FACP, SFHM, is a Board Certified Internal Medicine and Hospitalist physician and associate professor of medicine at the University of Nevada, Reno School of Medicine. He is internationally recognized as an outspoken critic of assisted suicide and euthanasia and a frequent contributor to legislative bodies and the media on this topic. Dr. Callister is the governor-elect of Nevada for the American College of Physicians and was nominated by Modern Healthcare as one of the 50 Most Influential Physician Executives in Healthcare. He is a Fellow of the American College of Physicians and a Senior Fellow of the Society of Hospital Medicine.

Callister's medical career has spanned four decades and he is a well-known speaker in the healthcare arena. He received his M.D. from the University of Utah School of Medicine where he graduated Alpha Omega Alpha. He graduated Phi Beta Kappa from Stanford University with a bachelor's degree in economics.

Dr. Callister Photo: https://bit.ly/2jpri2S

Dr. Callister CV: https://bit.ly/2FCIz1c

Media Contact:

Ira M. Gostin, MBA
120 West Strategic Communications
[email protected]
775-525-9371

SOURCE T. Brian Callister, M.D.


These press releases may also interest you

at 07:32
Duchesnay Pharmaceutical Group (DPG), one of the eight companies across the country chosen to participate in the Government of Canada's Global Hypergrowth Project, is very proud to announce that it has been awarded the Parity Certificationtm by Women...

at 06:30
The global microscopy market is poised for significant growth, expected to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, growing at a CAGR of 5.4%. Key drivers include rising cases of chronic diseases necessitating effective...

at 06:25
Genexine (KOSDAQ: 095700), a publicly-listed, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of serious unmet medical needs, announced a merger with EPD Biotherapeutics...

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...

at 06:00
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...



News published on and distributed by: